Prognostically-relevant molecular tumour subtypes can be distinguished based on the presence of additional drivers: a so-called ‘BSE mutation’ in BAP1, SF3B1 or EIF1AX and copy number alterations (CNAs) affecting chromosome 3p or 8q. This evidence concerns the gene SF3B1 and neoplasm.